Lebanon Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
112 Pages - SKU: BMI5325630
Countries covered: Lebanon

Lebanon Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: Lebanon's pharmaceutical sector is dominated by expensive drug imports as local firms'innovation and drug output remains low. We believe a multilateral approach to promoting generic drugs,increased local production and using competition to lower prices will dramatically improve Lebanon'sprospects for foreign direct investment. However, further drug price reductions with the health minister'srecently amended pharmaceutical bill, along with the country's ongoing political crisis, will contribute tobelow-potential market growth.

Headline Expenditure Projections

Pharmaceuticals: LBP2,056.94bn (USD1.36bn) in 2013 to LBP2,231.02bn (USD1.42bn) in 2014;+8.5% in local currency and +3.9.% in US dollar terms. Forecast adjusted to suit current marketconditions.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More Lebanon Prescription Drugs reports

Pharmaceuticals and Healthcare : Lebanon Pharmaceuticals and Healthcare Report Q3 2014 by Business Monitor International
Pharmaceuticals and Healthcare : Lebanon Pharmaceuticals and Healthcare Report Q3 2014BMI View: Lebanon benefits from a sizeable healthcare sector where the costs of health services ...
Antibiotics Market in Lebanon to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Lebanon. The study provides essential market ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!